Cellectis SA (NASDAQ:CLLS)

1.60
Delayed Data
As of Sep 25
 -0.12 / -6.98%
Today’s Change
1.58
Today|||52-Week Range
4.04
-23.81%
Year-to-Date

Stock Price Forecast

The 8 analysts offering 12-month price forecasts for Cellectis SA have a median target of 8.50, with a high estimate of 14.00 and a low estimate of 3.00. The median estimate represents a +431.25% increase from the last price of 1.60.

Analyst Recommendations

The current consensus among 9 polled investment analysts is to Buy stock in Cellectis SA. This rating has held steady since September, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.38
Sales
$5.9M
Reporting Date
Nov 09

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -101.35%
 
 
 
 
 
 
Growthannually 23.29%
 
 
 
 
 
 

Sales

Growthquarterly 192.85%
 
 
 
 
 
 
Growthannually -13.17%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.